The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States

Medicine & Life Sciences

• Lung Transplantation 66%
• Insurance 58%
• Allografts 50%
• Costs and Cost Analysis 35%
• Delivery of Health Care 35%
• Lung 30%
• International Classification of Diseases 9%
• Transplants 9%
• Transplantation 7%
• Health Care Outcome Assessment 6%
• Drug Costs 5%
• Terminology 4%
• Transplant Recipients 4%
• Health Care Costs 4%
• Lung Diseases 4%
• Inpatients 3%
• Cause of Death 3%
• Databases 2%

Social Sciences

• Commercial insurance 100%
• utilization 46%
• costs 32%
• resources 24%
• inpatient admission 12%
• International Classification 9%
• cause of death 8%
• technical language 6%
• recipient 6%
• incident 5%
• drug 4%
• cause 4%